News-Medical.Net on MSN
Proton therapy improves survival in oropharyngeal cancer patients
A new study published today in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who ...
6don MSN
Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers
A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were ...
Tech Xplore on MSN
Molecular fine-tuning boosts tandem solar cell efficiency to 31.4%
Perovskite-silicon tandem solar cells are considered a key technology for photovoltaics. Because of their design, they use ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...
Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the ...
MedPage Today on MSN
Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer
SAN ANTONIO -- Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune ...
One in two Australians will be diagnosed with cancer by the age of 85 — it is the leading cause of death in Australia.
NASA's Nancy Grace Roman Space Telescope team has released detailed plans for a major survey that will reveal our home galaxy ...
Discusses Innovative Approaches for Thyroid Artery Embolization and Tumor-Targeted Therapies December 15, 2025 2:00 ...
Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight ...
SurvivorNet on MSN
Enabling hope: Lilly’s head of oncology has a hugely ambitious plan to create the next wave of cancer drugs & incredible resources to make it happen
For Jacob Van Naarden, Executive Vice President and President of Lilly Oncology, the mission is clear: bring better cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results